These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17101087)

  • 1. [PCSK9, from gene to protein: a new actor involved in cholesterol homeostasis].
    Abifadel M; Rabès JP; Boileau C; Varret M
    Med Sci (Paris); 2006 Nov; 22(11):916-8. PubMed ID: 17101087
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.
    Abifadel M; Rabès JP; Devillers M; Munnich A; Erlich D; Junien C; Varret M; Boileau C
    Hum Mutat; 2009 Apr; 30(4):520-9. PubMed ID: 19191301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary PCSK9 variants: A new database.
    Leigh SE; Leren TP; Humphries SE
    Atherosclerosis; 2009 Mar; 203(1):32-3. PubMed ID: 19249440
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents.
    Abifadel M; Pakradouni J; Collin M; Samson-Bouma ME; Varret M; Rabès JP; Boileau C
    Expert Opin Ther Pat; 2010 Nov; 20(11):1547-71. PubMed ID: 20849207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the PCSK9 gene in Norwegian subjects with autosomal dominant hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 May; 65(5):419-22. PubMed ID: 15099351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Of PCSK9, cholesterol homeostasis and parasitic infections: possible survival benefits of loss-of-function PCSK9 genetic polymorphisms.
    Mbikay M; Mayne J; Seidah NG; Chrétien M
    Med Hypotheses; 2007; 69(5):1010-7. PubMed ID: 17502126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerating the pace of atherosclerosis research.
    Daugherty A; Tabas I; Rader DJ
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):11-2. PubMed ID: 25520521
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of novel mutations in the catalytic domain of the PCSK9 gene.
    Cameron J; Holla OL; Laerdahl JK; Kulseth MA; Ranheim T; Rognes T; Berge KE; Leren TP
    J Intern Med; 2008 Apr; 263(4):420-31. PubMed ID: 18266662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proprotein convertase subtilisin/kexin type 9, its variants and regulation of low-density lipoprotein cholesterol.
    Wierzbicki AS
    Curr Opin Lipidol; 2007 Apr; 18(2):227-9. PubMed ID: 17353672
    [No Abstract]   [Full Text] [Related]  

  • 10. The cellular trafficking of the secretory proprotein convertase PCSK9 and its dependence on the LDLR.
    Nassoury N; Blasiole DA; Tebon Oler A; Benjannet S; Hamelin J; Poupon V; McPherson PS; Attie AD; Prat A; Seidah NG
    Traffic; 2007 Jun; 8(6):718-32. PubMed ID: 17461796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia.
    Cunningham D; Danley DE; Geoghegan KF; Griffor MC; Hawkins JL; Subashi TA; Varghese AH; Ammirati MJ; Culp JS; Hoth LR; Mansour MN; McGrath KM; Seddon AP; Shenolikar S; Stutzman-Engwall KJ; Warren LC; Xia D; Qiu X
    Nat Struct Mol Biol; 2007 May; 14(5):413-9. PubMed ID: 17435765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease variants, LDL, and coronary heart disease.
    Tall AR
    N Engl J Med; 2006 Mar; 354(12):1310-2. PubMed ID: 16554535
    [No Abstract]   [Full Text] [Related]  

  • 13. Molecular biology of PCSK9: its role in LDL metabolism.
    Horton JD; Cohen JC; Hobbs HH
    Trends Biochem Sci; 2007 Feb; 32(2):71-7. PubMed ID: 17215125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.
    Abifadel M; Varret M; Rabès JP; Allard D; Ouguerram K; Devillers M; Cruaud C; Benjannet S; Wickham L; Erlich D; Derré A; Villéger L; Farnier M; Beucler I; Bruckert E; Chambaz J; Chanu B; Lecerf JM; Luc G; Moulin P; Weissenbach J; Prat A; Krempf M; Junien C; Seidah NG; Boileau C
    Nat Genet; 2003 Jun; 34(2):154-6. PubMed ID: 12730697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations of the PCSK9 gene cause variable phenotype of autosomal dominant hypercholesterolemia.
    Allard D; Amsellem S; Abifadel M; Trillard M; Devillers M; Luc G; Krempf M; Reznik Y; Girardet JP; Fredenrich A; Junien C; Varret M; Boileau C; Benlian P; Rabès JP
    Hum Mutat; 2005 Nov; 26(5):497. PubMed ID: 16211558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics: a gene of rare effect.
    Hall SS
    Nature; 2013 Apr; 496(7444):152-5. PubMed ID: 23579660
    [No Abstract]   [Full Text] [Related]  

  • 17. Unravelling the functional significance of PCSK9.
    Lambert G
    Curr Opin Lipidol; 2007 Jun; 18(3):304-9. PubMed ID: 17495605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.
    Maxwell KN; Breslow JL
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7100-5. PubMed ID: 15118091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.
    Rashid S; Curtis DE; Garuti R; Anderson NN; Bashmakov Y; Ho YK; Hammer RE; Moon YA; Horton JD
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5374-9. PubMed ID: 15805190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of genetic typing in human lipid disorders.
    Brown WV; Breslow J; Ballantyne C
    J Clin Lipidol; 2012; 6(3):199-207. PubMed ID: 22658144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.